Scientific advice on the suitability of data for the assessment of DNA integration into the fish genome of a genetically modified DNA plasmid-based veterinary vaccine
Pancreas disease caused by salmonid alphavirus in farmed Atlantic salmon (Salmo salar) leads to high mortality rates post infection and histopathological lesions in several organs. As protection against pancreas disease, Novartis developed a prophylactic DNA plasmid-based vaccine to be administered...
Main Author: | European Food Safety Authority |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-05-01
|
Series: | EFSA Journal |
Subjects: | |
Online Access: | http://www.efsa.europa.eu/en/efsajournal/doc/3232.pdf |
Similar Items
-
Assessment of the potential integration of the DNA plasmid vaccine CLYNAV into the salmon genome
by: European Food Safety Authority (EFSA), et al.
Published: (2017-01-01) -
Construction of a recombinant cDNA library and isolation of a plasmid containing thymidylate synthetase cDNA sequences /
by: Geyer, Pamela Kent
Published: (1983) -
Development of new plasmid DNA vaccine vectors with R1-based replicons
by: Bower Diana M, et al.
Published: (2012-08-01) -
Investigation of Plasmid DNA Delivery and Cell Viability Dynamics for Optimal Cell Electrotransfection In Vitro
by: Sonam Chopra, et al.
Published: (2020-09-01) -
Interaction of Big Celandine Extract and Plasmid DNA, Excreted From the Clinical Strain Escherichia Coli
by: E.G. Chebotarjova, et al.
Published: (2009-09-01)